Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Digestive System Disease
- Digestive System Neoplasm
- Esophageal Diseases
- Esophageal Neoplasms
- Esophagogastric Junction Disorder
- Gastrointestinal Disease
- Gastrointestinal Neoplasms
- Head and Neck Neoplasms
- Stomach Diseases
- Stomach Neoplasm
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Supportive Care
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
To evaluate the effect of Ocoxin-Viusid on the quality of life of patients To evaluate the toxicity of Ocoxin-Viusid in combination with chemotherapy (QT). To assess the influence of Ocoxin-Viusid on tolerance to treatment with chemotherapy. Identify the changes that occur in the nutritional status ...
To evaluate the effect of Ocoxin-Viusid on the quality of life of patients To evaluate the toxicity of Ocoxin-Viusid in combination with chemotherapy (QT). To assess the influence of Ocoxin-Viusid on tolerance to treatment with chemotherapy. Identify the changes that occur in the nutritional status of patients receiving the supplement.
Tracking Information
- NCT #
- NCT03549494
- Collaborators
- Not Provided
- Investigators
- Not Provided
Get Well Soon